UIA
GILD icon

UBP Investment Advisors’s Gilead Sciences GILD Stock Holding History

UBP Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,308
Closed -$209K – 82
2020
Q3 		$209K Buy
+3,308
New +$229K 0.16% 59

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBP Investment Advisors's GILD Position: Q4 2020 in Review

UBP Investment Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,308 shares — an estimated $209K sold.

UBP Investment Advisors first reported a position in GILD in Q3 2020 and held it in 1 quarter. The position peaked at $209K in Q3 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • UBP Investment Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • UBP Investment Advisors sold 3,308 Gilead Sciences shares in Q4 2020, an estimated $209K.
  • UBP Investment Advisors first reported a position in Gilead Sciences in Q3 2020 and held it in 1 quarter.
  • UBP Investment Advisors's Gilead Sciences position peaked at $209K in Q3 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on UBP Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.